01 1Heraeus Precious Metals GmbH & Co. KG
01 1cyclohexanediamine pyrophosphatoplatinum(ii), (1r,2r)-
01 1Germany
CYCLOHEXANEDIAMINE PYROPHOSPHATOPLATINUM(II), (1R,2R)-
NDC Package Code : 54875-0014
Start Marketing Date : 2013-05-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Cyclohexanediamine pyrophosphatoplatinum(II), (1R,2R)- manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cyclohexanediamine pyrophosphatoplatinum(II), (1R,2R)-, including repackagers and relabelers. The FDA regulates Cyclohexanediamine pyrophosphatoplatinum(II), (1R,2R)- manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cyclohexanediamine pyrophosphatoplatinum(II), (1R,2R)- API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cyclohexanediamine pyrophosphatoplatinum(II), (1R,2R)- supplier is an individual or a company that provides Cyclohexanediamine pyrophosphatoplatinum(II), (1R,2R)- active pharmaceutical ingredient (API) or Cyclohexanediamine pyrophosphatoplatinum(II), (1R,2R)- finished formulations upon request. The Cyclohexanediamine pyrophosphatoplatinum(II), (1R,2R)- suppliers may include Cyclohexanediamine pyrophosphatoplatinum(II), (1R,2R)- API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cyclohexanediamine pyrophosphatoplatinum(II), (1R,2R)- as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cyclohexanediamine pyrophosphatoplatinum(II), (1R,2R)- API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cyclohexanediamine pyrophosphatoplatinum(II), (1R,2R)- as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cyclohexanediamine pyrophosphatoplatinum(II), (1R,2R)- and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cyclohexanediamine pyrophosphatoplatinum(II), (1R,2R)- NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cyclohexanediamine pyrophosphatoplatinum(II), (1R,2R)- suppliers with NDC on PharmaCompass.
We have 1 companies offering Cyclohexanediamine pyrophosphatoplatinum(II), (1R,2R)-
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
